The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Percutaneous Ventricular Assist Units Market Research Report 2025
Synopsis
A percutaneous ventricular assist Units is a mechanical circulatory support device used to assist a weakened or failing heart by temporarily helping pump blood from the ventricles (lower chambers) of the heart to the rest of the body.
The global Percutaneous Ventricular Assist Units market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Percutaneous Ventricular Assist Units is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Percutaneous Ventricular Assist Units is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Percutaneous Ventricular Assist Units include Abiomed (Johnson & Johnson's), Supira Medical, Medtronic, Teleflex, LivaNova and Berlin Heart GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Percutaneous Ventricular Assist Units, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Ventricular Assist Units.
Report Scope
The Percutaneous Ventricular Assist Units market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Percutaneous Ventricular Assist Units market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Percutaneous Ventricular Assist Units manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abiomed (Johnson & Johnson's)
Supira Medical
Medtronic
Teleflex
LivaNova
Berlin Heart GmbH
Segment by Type
Insertion Percutaneous Ventricular Assist Units
Peripheral Percutaneous Ventricular Assist Units
Segment by Application
Hospital
Institution
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Percutaneous Ventricular Assist Units manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Percutaneous Ventricular Assist Units in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A percutaneous ventricular assist Units is a mechanical circulatory support device used to assist a weakened or failing heart by temporarily helping pump blood from the ventricles (lower chambers) of the heart to the rest of the body.
The global Percutaneous Ventricular Assist Units market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Percutaneous Ventricular Assist Units is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Percutaneous Ventricular Assist Units is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Percutaneous Ventricular Assist Units include Abiomed (Johnson & Johnson's), Supira Medical, Medtronic, Teleflex, LivaNova and Berlin Heart GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Percutaneous Ventricular Assist Units, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Ventricular Assist Units.
Report Scope
The Percutaneous Ventricular Assist Units market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Percutaneous Ventricular Assist Units market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Percutaneous Ventricular Assist Units manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abiomed (Johnson & Johnson's)
Supira Medical
Medtronic
Teleflex
LivaNova
Berlin Heart GmbH
Segment by Type
Insertion Percutaneous Ventricular Assist Units
Peripheral Percutaneous Ventricular Assist Units
Segment by Application
Hospital
Institution
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Percutaneous Ventricular Assist Units manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Percutaneous Ventricular Assist Units in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Percutaneous Ventricular Assist Units Market Overview
1.1 Product Overview and Scope of Percutaneous Ventricular Assist Units
1.2 Percutaneous Ventricular Assist Units Segment by Type
1.2.1 Global Percutaneous Ventricular Assist Units Market Value Comparison by Type (2024-2030)
1.2.2 Insertion Percutaneous Ventricular Assist Units
1.2.3 Peripheral Percutaneous Ventricular Assist Units
1.3 Percutaneous Ventricular Assist Units Segment by Application
1.3.1 Global Percutaneous Ventricular Assist Units Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Institution
1.3.4 Clinic
1.3.5 Others
1.4 Global Percutaneous Ventricular Assist Units Market Size Estimates and Forecasts
1.4.1 Global Percutaneous Ventricular Assist Units Revenue 2019-2030
1.4.2 Global Percutaneous Ventricular Assist Units Sales 2019-2030
1.4.3 Global Percutaneous Ventricular Assist Units Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Percutaneous Ventricular Assist Units Market Competition by Manufacturers
2.1 Global Percutaneous Ventricular Assist Units Sales Market Share by Manufacturers (2019-2024)
2.2 Global Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Percutaneous Ventricular Assist Units Average Price by Manufacturers (2019-2024)
2.4 Global Percutaneous Ventricular Assist Units Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Percutaneous Ventricular Assist Units, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Percutaneous Ventricular Assist Units, Product Type & Application
2.7 Percutaneous Ventricular Assist Units Market Competitive Situation and Trends
2.7.1 Percutaneous Ventricular Assist Units Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Percutaneous Ventricular Assist Units Players Market Share by Revenue
2.7.3 Global Percutaneous Ventricular Assist Units Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Percutaneous Ventricular Assist Units Retrospective Market Scenario by Region
3.1 Global Percutaneous Ventricular Assist Units Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Percutaneous Ventricular Assist Units Global Percutaneous Ventricular Assist Units Sales by Region: 2019-2030
3.2.1 Global Percutaneous Ventricular Assist Units Sales by Region: 2019-2024
3.2.2 Global Percutaneous Ventricular Assist Units Sales by Region: 2025-2030
3.3 Global Percutaneous Ventricular Assist Units Global Percutaneous Ventricular Assist Units Revenue by Region: 2019-2030
3.3.1 Global Percutaneous Ventricular Assist Units Revenue by Region: 2019-2024
3.3.2 Global Percutaneous Ventricular Assist Units Revenue by Region: 2025-2030
3.4 North America Percutaneous Ventricular Assist Units Market Facts & Figures by Country
3.4.1 North America Percutaneous Ventricular Assist Units Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Percutaneous Ventricular Assist Units Sales by Country (2019-2030)
3.4.3 North America Percutaneous Ventricular Assist Units Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Percutaneous Ventricular Assist Units Market Facts & Figures by Country
3.5.1 Europe Percutaneous Ventricular Assist Units Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Percutaneous Ventricular Assist Units Sales by Country (2019-2030)
3.5.3 Europe Percutaneous Ventricular Assist Units Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Percutaneous Ventricular Assist Units Market Facts & Figures by Country
3.6.1 Asia Pacific Percutaneous Ventricular Assist Units Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Percutaneous Ventricular Assist Units Sales by Country (2019-2030)
3.6.3 Asia Pacific Percutaneous Ventricular Assist Units Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Percutaneous Ventricular Assist Units Market Facts & Figures by Country
3.7.1 Latin America Percutaneous Ventricular Assist Units Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Percutaneous Ventricular Assist Units Sales by Country (2019-2030)
3.7.3 Latin America Percutaneous Ventricular Assist Units Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Percutaneous Ventricular Assist Units Market Facts & Figures by Country
3.8.1 Middle East and Africa Percutaneous Ventricular Assist Units Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Percutaneous Ventricular Assist Units Sales by Country (2019-2030)
3.8.3 Middle East and Africa Percutaneous Ventricular Assist Units Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Percutaneous Ventricular Assist Units Sales by Type (2019-2030)
4.1.1 Global Percutaneous Ventricular Assist Units Sales by Type (2019-2024)
4.1.2 Global Percutaneous Ventricular Assist Units Sales by Type (2025-2030)
4.1.3 Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2019-2030)
4.2 Global Percutaneous Ventricular Assist Units Revenue by Type (2019-2030)
4.2.1 Global Percutaneous Ventricular Assist Units Revenue by Type (2019-2024)
4.2.2 Global Percutaneous Ventricular Assist Units Revenue by Type (2025-2030)
4.2.3 Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2019-2030)
4.3 Global Percutaneous Ventricular Assist Units Price by Type (2019-2030)
5 Segment by Application
5.1 Global Percutaneous Ventricular Assist Units Sales by Application (2019-2030)
5.1.1 Global Percutaneous Ventricular Assist Units Sales by Application (2019-2024)
5.1.2 Global Percutaneous Ventricular Assist Units Sales by Application (2025-2030)
5.1.3 Global Percutaneous Ventricular Assist Units Sales Market Share by Application (2019-2030)
5.2 Global Percutaneous Ventricular Assist Units Revenue by Application (2019-2030)
5.2.1 Global Percutaneous Ventricular Assist Units Revenue by Application (2019-2024)
5.2.2 Global Percutaneous Ventricular Assist Units Revenue by Application (2025-2030)
5.2.3 Global Percutaneous Ventricular Assist Units Revenue Market Share by Application (2019-2030)
5.3 Global Percutaneous Ventricular Assist Units Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abiomed (Johnson & Johnson's)
6.1.1 Abiomed (Johnson & Johnson's) Corporation Information
6.1.2 Abiomed (Johnson & Johnson's) Description and Business Overview
6.1.3 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Portfolio
6.1.5 Abiomed (Johnson & Johnson's) Recent Developments/Updates
6.2 Supira Medical
6.2.1 Supira Medical Corporation Information
6.2.2 Supira Medical Description and Business Overview
6.2.3 Supira Medical Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Supira Medical Percutaneous Ventricular Assist Units Product Portfolio
6.2.5 Supira Medical Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Percutaneous Ventricular Assist Units Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Teleflex
6.4.1 Teleflex Corporation Information
6.4.2 Teleflex Description and Business Overview
6.4.3 Teleflex Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teleflex Percutaneous Ventricular Assist Units Product Portfolio
6.4.5 Teleflex Recent Developments/Updates
6.5 LivaNova
6.5.1 LivaNova Corporation Information
6.5.2 LivaNova Description and Business Overview
6.5.3 LivaNova Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LivaNova Percutaneous Ventricular Assist Units Product Portfolio
6.5.5 LivaNova Recent Developments/Updates
6.6 Berlin Heart GmbH
6.6.1 Berlin Heart GmbH Corporation Information
6.6.2 Berlin Heart GmbH Description and Business Overview
6.6.3 Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Portfolio
6.6.5 Berlin Heart GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Percutaneous Ventricular Assist Units Industry Chain Analysis
7.2 Percutaneous Ventricular Assist Units Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Percutaneous Ventricular Assist Units Production Mode & Process
7.4 Percutaneous Ventricular Assist Units Sales and Marketing
7.4.1 Percutaneous Ventricular Assist Units Sales Channels
7.4.2 Percutaneous Ventricular Assist Units Distributors
7.5 Percutaneous Ventricular Assist Units Customers
8 Percutaneous Ventricular Assist Units Market Dynamics
8.1 Percutaneous Ventricular Assist Units Industry Trends
8.2 Percutaneous Ventricular Assist Units Market Drivers
8.3 Percutaneous Ventricular Assist Units Market Challenges
8.4 Percutaneous Ventricular Assist Units Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
